{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:09:38Z","timestamp":1778620178729,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0107800"],"award-info":[{"award-number":["2018YFA0107800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670137"],"award-info":[{"award-number":["81670137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470311"],"award-info":[{"award-number":["81470311"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800147"],"award-info":[{"award-number":["81800147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["20152501"],"award-info":[{"award-number":["20152501"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jmoldx.2021.07.019","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:30:03Z","timestamp":1628548203000},"page":"1478-1490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Application of Targeted RNA Sequencing for KMT2A\u2013Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"23","author":[{"given":"Bing","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichen","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-5962","authenticated-orcid":false,"given":"Yunxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-0523","authenticated-orcid":false,"given":"Lu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1012-2007","authenticated-orcid":false,"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2021.07.019_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.seminhematol.2018.08.002","article-title":"The 2016 WHO classification of acute myeloid leukemia: what the practicing clinician needs to know","volume":"56","author":"Arber","year":"2019","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.1996.d01-1748.x","article-title":"Exon\/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias","volume":"93","author":"Nilson","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06301.x","article-title":"The MLL partial tandem duplication in acute myeloid leukaemia","volume":"135","author":"Basecke","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.leu.2401773","article-title":"Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML","volume":"14","author":"Schnittger","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/gcc.10219","article-title":"Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia","volume":"37","author":"Steudel","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib7","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1200\/JCO.2002.09.088","article-title":"Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm","volume":"20","author":"D\u00f6hner","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1200\/JCO.2016.71.2208","article-title":"Genomics of acute myeloid leukemia diagnosis and pathways","volume":"35","author":"Bullinger","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/10428194.2017.1352091","article-title":"The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia","volume":"59","author":"Kong","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib10","first-page":"881","article-title":"Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy","volume":"90","author":"Weisser","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.leukres.2014.11.017","article-title":"Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias","volume":"39","author":"Burmeister","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/bjh.12792","article-title":"Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene","volume":"165","author":"Ommen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib13","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3324\/haematol.2018.205955","article-title":"Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia","volume":"104","author":"Levine","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib14","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.3324\/haematol.2019.230821","article-title":"RNAmut: robust identification of somatic mutations in acute myeloid leukemia using RNA-sequencing","volume":"105","author":"Gu","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1541-7786.MCR-17-0569","article-title":"Targeted next-generation sequencing for detecting MLL gene fusions in leukemia","volume":"16","author":"Afrin","year":"2018","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2015-11-683334","article-title":"Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies","volume":"128","author":"McKerrell","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib17","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12864-016-3425-4","article-title":"Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller","volume":"18","author":"Xu","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib19","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ijlh.12802","article-title":"Mutation profile and associated clinical features in Chinese patients with cytogenetically normal acute myeloid leukemia","volume":"40","author":"Wang","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib21","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1182\/blood-2017-12-819508","article-title":"RNA-based FLT3-ITD allelic ratio is associated with outcome and ex\u00a0vivo response to FLT3 inhibitors in pediatric AML","volume":"131","author":"Cucchi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib23","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13059-019-1863-4","article-title":"Systematic comparative analysis of single-nucleotide variant detection methods from single-cell RNA sequencing data","volume":"20","author":"Liu","year":"2019","journal-title":"Genome Biol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/jclinpath-2017-204825","article-title":"CEBPA mutational analysis in acute myeloid leukaemia by a laboratory-developed next-generation sequencing assay","volume":"71","author":"Ng","year":"2018","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib27","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41375-019-0483-z","article-title":"getITD for FLT3-ITD-based MRD monitoring in AML","volume":"33","author":"Bl\u00e4tte","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib28","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.6004\/jnccn.2019.0028","article-title":"Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Tallman","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/genes10121026","article-title":"Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia","volume":"10","author":"Cumbo","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cancergen.2019.10.006","article-title":"Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-rearranged acute myeloid leukemia","volume":"240","author":"Vetro","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2016.160","article-title":"Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)","volume":"31","author":"Sun","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib34","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/HS9.0000000000000181","article-title":"The landscape of KMT2A-PTD AML: concurrent mutations, gene expression signatures, and clinical outcome","volume":"3","author":"Al Hinai","year":"2019","journal-title":"Hemasphere"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib35","first-page":"973","article-title":"Indel detection from RNA-seq data: tool evaluation and strategies for accurate detection of actionable mutations","volume":"18","author":"Sun","year":"2017","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib36","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1038\/ncomms9554","article-title":"Systematic analysis of somatic mutations impacting gene expression in 12 tumour types","volume":"6","author":"Ding","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3324\/haematol.2018.194258","article-title":"Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing","volume":"104","author":"Mack","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrg.2017.117","article-title":"Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations","volume":"19","author":"Salk","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib39","doi-asserted-by":"crossref","first-page":"33217","DOI":"10.18632\/oncotarget.5202","article-title":"High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis","volume":"6","author":"Kao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41389-020-0191-6","article-title":"DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells","volume":"9","author":"Bera","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-014-0074-4","article-title":"Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations","volume":"7","author":"Loghavi","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib42","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood.2018862383","article-title":"Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML","volume":"134","author":"Garg","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib44","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-02-829911","article-title":"Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML","volume":"132","author":"Thol","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2018.203133","article-title":"Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia","volume":"104","author":"Dillon","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib46","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood-2017-09-801498","article-title":"Minimal\/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party","volume":"131","author":"Schuurhuis","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/leu.2013.248","article-title":"Clonal evolution in hematological malignancies and therapeutic implications","volume":"28","author":"Landau","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2021.07.019_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41375-020-0762-8","article-title":"Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing","volume":"35","author":"Arindrarto","year":"2021","journal-title":"Leukemia"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157821002440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157821002440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:39Z","timestamp":1778616459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157821002440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1525157821002440"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2021.07.019","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Application of Targeted RNA Sequencing for KMT2A\u2013Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2021.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}